Vogt-Koyanagi-Harada Syndrome

Main Article Content

อาจารย์แพทย์หญิงสุพินดา ลีอมรสิริ

Abstract

Vogt-Koyanagi-Harada (VKH) Syndrome เป็นโรคตาอักเสบที่พบได้บ่อยในประเทศไทย มักพบร่่่่่่่่่่่่่่วมกับความผิดปกติของระบบประสาท หู และผิวหนัง กลไกลการเกิดโรคยังไม่ทราบแน่ชัดแต่เชื่อว่าเกิดจากความผิดปกติของภูมิคุ้มกันของร่างกายต่อ melanin การวินิจฉัยโรคตั้งแต่ระยะแรกและให้การรักษาอย่างเหมาะสมด้วยยา corticosteroids ในขนาดสูงเป็นเวลานานร่วมกับการใช้ยากดภูมิต้านทาน (immunosuppressive drugs) จะช่วยให้ผู้ป่วยมีการมองเห็นที่ดีและการพยากรณ์โรคที่ดีได้

Downloads

Download data is not yet available.

Article Details

Section
Review Article

References

Sheu SJ. Update on uveomeningoence phalitides. Curr Opin Neurol. 2005 Jun;

(3):323-9.

Vogt A. Fruhzeitiges Ergaruen der Zilien und Bemerkungen uber den sogenaten plotzlichen

Eintreitt dieser Veraderung. Klin Monatsbl Augenheikd. 1906;44:228-42.

Koyanagi Y. Dysakusis, Alopecia und Poliosis bei schwerer Uveitis nicht traumatischen

Ursprugs. Klin Monatsbl Augenheikd. 1929; 82:194-211.

Harada E. Acute diffuse choroiditis. Acta Soc Ophthalmol Jpn. 1926;30:356-78.

Babel J. Sundrome de Vogt-Koyanagi (Uveite bilaterale, poliosis, alopecie, vitiligo et

dyacousie). Schweiz Med Wochenschr Nr.1932;44:1136-40.

Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular

inflammatory disease in Japan. Ocul Immunol Inflamm. 2003 Dec;11(4):277-86.

Murthy SI, Moreker MR, Sangwan VS, Khanna RC, Tejwani S. The spectrum of Vogt-

Koyanagi-Harada disease in South India. Int Ophthalmol. 2007 Apr-Jun;27(2-3):131-6.

Chee SP, Jap A, Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore.

Int Ophthalmol. 2007 Apr-Jun;27(2-3):137-42.

Rajendram R, Evans M, Rao NA. Vogt- Koyanagi-Harada disease. Int Ophthalmol Clin.

Spring;45(2):115-34.

Sukavatcharin S, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease in Hispanic patients.

Int Ophthalmol. 2007 Apr-Jun;27(2-3):143-8.

Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol.

Jul-Sep;20(3):183-90.

Khairallah M, Zaouali S, Messaoud R,Chaabane S, Attia S, Ben Yahia S, et al. The

spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa. Int Ophthalmol. 2007

Apr-Jun;27(2-3):125-30.

Khairallah M, Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, et al. Pattern of uveitis

in a referral centre in Tunisia, North Africa. Eye (Lond). 2007 Jan;21(1):33-9.

Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M, et al. The spectrum of

Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol. 2007

Apr-Jun;27(2-3):117-23.

Tesavibul N, Sansanayuth W. Vogt-Koyanagi- Harada disease in Thai patients. J Med Assoc

Thai. 2005 Nov;88 Suppl 9:S26-30.

Keino H, Nakashima C, Watanabe T, Taki W, Hayakawa R, Sugitani A, et al. Frequency and

clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol. 2009

Aug;37(6):595-601.

Bassili SS, Peyman GA, Gebhardt BM, Daun M, Ganiban GJ, Rifai A. Detection of Epstein-

Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-

Koyanagi-Harada syndrome. Retina. 1996;16(2):160-1.

Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase

peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol.2007 Apr-Jun;27(2-3):87-95.

Sene D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N, et al. Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol. 2007 Jun 14;13(22): 3137-40.

Kasahara A, Hiraide A, Tomita N, Iwahashi H, Imagawa A, Ohguro N, et al. Vogt-

Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis

C. J Gastroenterol. 2004 Nov;39(11):1106-9.

Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are

antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000 Dec 15;165(12):7323-9.

Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, et al. Ocular infiltrating

CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human

melanocyte antigens. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2547-54.

Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res. 2008 Jul;33(7):517-23.

Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006

Spring;46(2):111-22.

Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, et al. IL-23 promotes CD4+ T cells to produce

IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007 May;119(5):1218-24.

Perry HD, Font RL. Clinical and histopathologic observations in severe Vogt-Koyanagi-

Harada syndrome. Am J Ophthalmol. 1977 Feb;83(2):242-54.

Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-

Harada disease. Am J Ophthalmol. 2001 May;131(5):607-14.

Ohno S, Char DH, Kimura SJ, OuConnor GR.Vogt-Koyanagi-Harada syndrome. Am J

Ophthalmol. 1977 May;83(5):735-40.

Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35.

Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Haradaus disease.

Jpn J Ophthalmol. 1988;32(3):334-43.

Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications

and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001 May;131(5):599-606.

Kuo IC, Rechdouni A, Rao NA, Johnston RH, Margolis TP, Cunningham ET, Jr. Subretinal

fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology. 2000 Sep;107(9):

-8.

Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980

Jul;90(1):69-75.

Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised

diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee

on nomenclature. Am J Ophthalmol. 2001 May;131(5):647-52.

Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the

appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001 Jan;108(1):54-64.

Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-

Harada syndrome. Arch Ophthalmol. 1990 Oct;108(10):1421-6.

Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-

Harada disease. Ophthalmologica. 1990;201 (3):162-7.

Yamanaka E, Ohguro N, Yamamoto S,Nakagawa Y, Imoto Y, Tano Y. Evaluation of

pulse corticosteroid therapy for vogt-koyanagiharada disease assessed by optical coherence

tomography. Am J Ophthalmol. 2002 Sep;134(3):454-6.

Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, et al. Evaluation of the effect

on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada

disease. Am J Ophthalmol. 2006 Jul;142(1): 119-24.

Biswas J, Roa NA. Management of intraocular inflammation. In: Ryan SJ, editor. Retina. St.

Louis: Mosby-Year book; 1994.

Roa NA, Blackman HJ, Franklin RM, et al. Intraocular inflammation and uveitis. In: Basic

and clinical science course 1998-1999. San Francisco: American Academy of Ophthalmology;

Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-

Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006 Apr;14(2):87-90.